|  | Conditions Treatments | Diseases

Early Stage T Cell Lymphoma Prognosis

T-cell lymphomas are an uncommon type of non-Hodgkin lymphoma, making up about 10 percent of all non-Hodgkin lymphomas. Because there are a number of subtypes of T-cell lymphoma and each is relatively rare, it's difficult to pinpoint an accurate prognosis. Lymphoma is a cancer of the lymphocytes, or a type of white blood cell. T cells are a specific type of lymphocyte.

  1. Overall non-Hodgkin statistics

    • In 2009, there were 65,980 new cases of non-Hodgkin lymphoma in the United States, and a reported 19,500 deaths from it, according to the National Cancer Institute. Overall, an estimated 50 percent to 80 percent of all NHL patients survive five years or more.

    T-Cell vs. B-Cell survival rates

    • Generally, the survival rates are higher for B-cell lymphomas over T-cell. This is most likely due to the fact that there are fewer cases of T-cell lymphomas and less is known about what the best treatments are for each of the various subtypes.

    Factors

    • Prognosis varies by type, stage of the illness when diagnosed and overall health and age of the patient.

    Survival and cure rates

    • More aggressive forms of non-Hodgkin lymphomas may be fatal, but have a higher likelihood of being cured with chemotherapy. The lower-grade lymphomas have a longer survival rate, often 10 or more years, but are often not curable.

    Survival rates by type

    • Cutaneous anaplastic large cell has the best prognosis, with a 78 percent, five-year survival rate, while peripheral T-cell, anaplastic large T/null cell and angioimmunoblastic lymphoma have a five-year survival rate together of 38 percent to 43 percent. Extranodal NK/T-cell lymphoma and enteropathy-type lymphoma are in the lowest five-year survival rate category, with a prognosis of 22 percent to 24 percent.

Diseases - Related Articles